Inoue, K.; Iida, N.; Tajiri, K.; Bando, H.; Chiba, S.; Tasaka, N.; Nagashio, K.; Sasamura, R.; Naito, H.; Murata, M.;
et al. Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry). J. Clin. Med. 2021, 10, 1370.
https://doi.org/10.3390/jcm10071370
AMA Style
Inoue K, Iida N, Tajiri K, Bando H, Chiba S, Tasaka N, Nagashio K, Sasamura R, Naito H, Murata M,
et al. Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry). Journal of Clinical Medicine. 2021; 10(7):1370.
https://doi.org/10.3390/jcm10071370
Chicago/Turabian Style
Inoue, Keiko, Noriko Iida, Kazuko Tajiri, Hiroko Bando, Shigeru Chiba, Nobutaka Tasaka, Kenji Nagashio, Rumi Sasamura, Hiroyuki Naito, Momoko Murata,
and et al. 2021. "Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)" Journal of Clinical Medicine 10, no. 7: 1370.
https://doi.org/10.3390/jcm10071370
APA Style
Inoue, K., Iida, N., Tajiri, K., Bando, H., Chiba, S., Tasaka, N., Nagashio, K., Sasamura, R., Naito, H., Murata, M., Li, S., Ishizu, T., Nakazawa, Y., Sekine, I., & Ieda, M.
(2021). Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry). Journal of Clinical Medicine, 10(7), 1370.
https://doi.org/10.3390/jcm10071370